Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis

Table 3

Subgroup analyses.

Clinical presentation
	Stable CAD and CABG; OR (CI)	STEMI; OR (CI)	value	NSTEMI; OR (CI)	value
All-cause mortality	0.87 (0.71-1.07)	0.89 (0.59-1.34)	0.92	2.47 (0.47-13.08)	0.22
Stroke	0.97 (0.60-1.55)	1.06 (0.69-1.62)	0.78	2.90 (0.12-72.20)	0.51
Recurrent MI	0.94 (0.81-1.09)	1.20 (0.89-1.62)	0.15	4.309 (0.84-19.84)	0.06
Revascularization	0.93 (0.82-1.09)	—	—	1.060 (0.65-3.95)	0.78
MACCE	0.81 (0.65-1.01)	1.02 (0.91-1.13)	0.07	1.29 (0.94-1.77)	0.02
Timing after acute event
	≤7 days		>7 days
All-cause mortality	1.08 (0.82-1.41)		0.94 (0.87-1.02)		0.33
Cardiac mortality	1.12 (0.70-1.79)		0.92 (0.83-1.02)		0.42
Stroke	1.03 (0.70-1.50)		0.90 (0.70-1.16)		0.56
Recurrent MI	1.34 (0.97-1.86)		0.92 (0.86-0.99)		0.03
Revascularization	1.54 (0.70-3.36)		0.83 (0.71-0.98)		0.03
MACCE	1.08 (0.93-1.26)		0.91 (0.82-1.00)		0.06
Clinical presentation
	ACS		Non-ACS
All-cause mortality	0.99 (0.88-1.11)		0.87 (0.71-1.07)		0.28
Cardiac mortality	0.92 (0.81-1.04)		0.94 (0.80-1.10)		0.84
Stroke	0.93 (0.74-1.16)		0.97 (0.60-1.55)		0.88
Recurrent MI	1.08 (0.91-1.27)		0.88 (0.80-0.98)		0.04
Revascularization	0.83 (0.65-1.07)		0.93 (0.82-1.05)		0.42
MACCE	0.99 (0.91-1.08)		0.83 (0.68-1.01)		0.11